Nephrectomy is necessary in the treatment of metastatic renal cell carcinoma

Journal of the Canadian Urological Association

Volumn 4, Issue 1, 2010, Pages 65-67

  Youssif, Tamer Abou ^a   Tanguay, Simon ^a  

^a MCGILL UNIVERSITY HEALTH CENTRE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 76149095955     PISSN: 19116470     EISSN: 19116470     Source Type: Journal    
DOI: 10.5489/cuaj.778     Document Type: Article

References (10)

1. Flanigan RC, Salmon SE, Blumenstein BA et al. Nephrectomy followed by interferon alfa-2b compared with interferon alfa-2b alone for metastatic renal-cell cancer. N Engl J Med 2001;345:1655-9.
2. Mickisch GH, Garin A, van Poppel H, et al. Radical nephrectomy plus interferon alfa-based immunotherapy compared with interferon alfa alone in metastatic renal-cell carcinoma: a randomized trial. Lancet 2001;358:966-70.
3. Flanigan RC, Mickisch G, Sylvester R, et al. Cytoreductive nephrectomy in patients with metastatic renal cancer: a combined analysis. J Urol 2004;171:1071-6.
4. Belldegrun A, Shvarts O, Figlin RA. Expanding the indications for surgery and adjuvant interleukin-2-based immunotherapy in patients with advanced renal cell carcinoma. Cancer J Sci Am 2000;6Suppl1:S88-92.
5. Zini L, Capitanio U, Perrotte P, et al. Population-based assessment of survival after cytoreductive nephrectomy versus no surgery in patients with metastatic renal cell carcinoma. Urology 2009;73:342-6.
6. Chagnon F, Tanguay S, Ozdal OL, et al. Potentiation of a dendritic cell vaccine for murine renal cell car- cinoma by CpG oligonucleotides. Clin Cancer Res 2005;11:1302-11.
7. Kudo A, Rayman P, Horton C, et al. Gangliosides expresses by renal cell carcinoma cell line SK-RC-45 are involved in tumour-induced apoptosis of T cells. Cancer Res 2003;63:1676-83.
8. Ng CS, Novick AC, Tannenbaum CS, et al. Mechanisms of immune evasion by renal cell carcinoma: tumour-induced T-lymphocyte apoptosis and NFkB suppression. Urology 2002;59:9-14.
9. Gigante M, Blasi A, Loverre A, et al. Dysfunctional DC subsets in RCC patients: Ex vivo correction to yield an effective anti-cancer vaccine. Mol Immunol 2008;46:893-901.
10. Halbert RJ, Figlin RA, Atkins MB, et al. Treatment of patients with metastatic renal cell cancer: a RAND Appropriateness Panel. Cancer 2006;107:2375-83.